Luciana Thaís Rangel Souza, Cecília Correia Costa, Mateus Cardoso Oliveira, Isabel Celeste Caires Pereira Gusmão


Aim: to evaluate the in vitro action of thymol and carvacrol against the yeasts of Candida albicans ATCC10231 and Candida krusei ATCC34135. Method: A laboratory study was performed to evaluate antifungal activity. The characterization of the Minimal Inhibitory Concentration (MIC) of the thymol essential oil was carried out using the technique where the microdilution is performed, in which a plate containing 96 wells is used. The determination of the Minimum Fungicidal Concentration (MFC) was performed by dripping 10 μL of each of the concentrations evaluated on Sabouraud agar plates. Results: The MIC of thymol and carvacrol for C. albicans was 40 μg/mL and for Candida krusei it did not present antifungal activity. While the MIC of nystatin was 0.03mg for both species with thymol and carvacrol. Conclusion: Thymol presented satisfactory antifungal activity against the pathogens studied, but carvacrol did not present antifungal activity.


Fitoterapia, Lippia origanoides,Timol.

Texto completo:

PDF (English) PDF


Lima IO, Pereira FO, Oliveira WA. Antifungal activity and mode of action of carvacrol against Candida albicans strains. J Essent Oil Res. 2013 jan [ cited 2018 Jan 21]; 25:138-42. Available form:

Manohar V, Ingram C, Gray J, Talpur NA, Echard BW, Bagchi D, Preuss HG. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem. 2001 Jan [ cited 2018 Jan 21]; 228:111-7. Available form:

Lee SH, Lee JR, Lunde CS, Kubo I. In vitro antifungal susceptibilities of Candida albicans and other fungal pathogens to polygodial, a sesquiterpene dialdehyde. Planta Médica 1999 Abr [cited 2018 Jan 21] 65:204-8. Available form:

Segal, E. Candida still numberone – what do weknowandwherewegoingfromthere? Mycoses 2005 Fev [ cited 2018 Jan 21]; 48(1):1-15. Available form:

Pozzatti P, Loreto ES, Lopes PG, Athayde ML, Santurio JM, Alves SH. Comparison of the susceptibilities of clinical isolates of Candida albicans and Candida dubliniensis to essential oils. Mycoses. 2010 Jan [ cited 2018 Jan 21]; 53:12-5. Available form:

CLSI - CLINICAL AND LABORATORY STANDARDS INSTITUTE. Método de referência para testes de diluição em caldo para a determinaçao da sensibilidade de leveduras à terapia antifúngica: Norma Aprovada. 2.ed. Norma M27-A2 do CLSI. Pennsylvania: ANVISA; 2008.

Greco WR, Bravo G, Parsons JC. The search for synergy: a critical review from a response surface perspective. Pharmacol Rev. 1995 Jun [ cited 2018 Jan 21]; 47:331-85. Available form:

Khozeimeh F, Shahtalebi MA, Noori M, Savabi O. Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in orabase in treatment of Candida-infected denture stomatitis. J Contemp Dent Pract. 2010 Mar [ cited 2018 Jan 21]; 11:17-24. Available form:

Bicmen C, Doluca M, Gulat S, Gunduz AT, Tuksavul F. Species level identification and antifungal susceptibility of yeast isolated from various clinical specimens and evaluation of Integral System Yeasts PlusNew Microbiology. 2014 Jun [cited 2018 Jan 21]; 35:327-34. Available form:

Alczuk SDES, Bonfim PDESM, Rocha SCM, Shinobu CSM, Martins HP, Gimenese F, et al. Effect of highly active antirretroviral therapyon vaginal Candida spp. isolation in hivinfected compared to hiv-um infected women. Rev. do Inst. de Med. Trop. S. Paulo. 2015 Apr [cited 2018 Jan 21]; 57(2):169-74. Available form:

Keniya MV, Fleischer E, Klinger R, Cannon RD, Monk BC. Inhibitors of the Candida albicans major facilitator super family transporter Mdr1p responsible for fluconazole e resistance. PLoS One. 2015 May [cited 2018 Jan 21]; 10(5):16-28. Available form:

Medeiros CIS, Oliveira HMF, Souza JP, Oliveira FAA, Lima EO. Atividade anti-Candida tropicalis dos enantiômeros (R)-(+)- & (S)-(-)-citronelal em associação com nistatina. Arch Health Invest. 2018 Fev [ cited 2018 Jan 21]; 7:40-43. Available form:

Costa ACB, Pereira CA, Freire F, Junqueira JC, Jorge AOC. Atividade antifúngica dos extratos glicólicos de Rosmarinus officinalis Linn e Syzygium cumini Linn. sobre cepas clínicas de Candida albicans, Candida glabrata e Candida tropicalis. Rev. de Odontol. Da UNESP. 2009 Mar [ cited 2018 Jan 21]; 38(2):111-6. Available form:

Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003 [cited 2018 Jan 21]; 52:1. Available form:



  • Não há apontamentos.


Internacionais: CuidenIndex Copernicus InternationalResearch BibleLatindexCrossRefScholar Google; REDIB; PKP Index; DOAJ; MIAR; Biblioteca Virtual em Saúde (BVS); BDEnf.

Nacionais: DiadorimIBICTSumarios.orgLIVRE; periodicos CAPES.

REPIS is available in: Publons

ISSN: 2446-7901